EVH Evolent Health, Inc.

NYSE
$3.61

Evolent Health, Inc. (EVH) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.5% since its last earnings release on August 6, 2026.

Evolent Health Missed Consensus Estimates, Raises Guidance
Thursday, August 6, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.05)
Rev est $734.32M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.20

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Evolent Health, Inc.

Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable.

Sector

Healthcare

Industry

Healthcare Info Services

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.